Sign in →

Test ID NBLD0487 EGFR Gene, Mutation Analysis, 29 Mutation Panel, Tumor

Useful For

Identifying non-small cell lung cancers that may respond to epidermal growth factor receptor-tyrosine kinase inhibitor therapies

Specimen Type

Varies


Specimen Required


Pathology report must accompany specimen in order for testing to be performed.

 

Preferred:

Specimen Type: Tissue

Container/Tube: Tissue block

Collection Instructions: Submit a formalin-fixed, paraffin-embedded tissue block.

 

Acceptable:

Specimen Type: Tissue

Container/Tube: Slides

Specimen Volume: 1 stained and 5 unstained

Collection Instructions: Submit 1 slide stained with hematoxylin and eosin and 5 unstained, non-baked slides with 5-micron thick sections of the tumor tissue.


Specimen Minimum Volume

Formalin-fixed, paraffin-embedded (FFPE) tissue block (preferred) or 1 slide stained with hematoxylin and eosin and 5 unstained, nonbaked slides with 5-microns thick sections of the tumor tissue.

Reject Due To

Hemolysis

NA

Lipemia

NA

Icterus

NA

Other

Specimens that have been decalcified (all methods); specimens that have not been formalin-fixed, paraffin-embedded; bone marrow in EDTA

Specimen Stability Information

Specimen Type Temperature Time
Varies Ambient (preferred)
  Frozen 
  Refrigerated 

Day(s) and Time(s) Performed

Monday through Friday; 10 a.m.

Analytic Time

5 days

Method Name

Polymerase Chain Reaction (PCR) Analysis

Performing Laboratory

Mayo Clinic Laboratories in Rochester

CPT Code Information

EGFR Gene, Mutation Analysis, 29 Mutation Panel, Tumor 

81235-EGFR (epidermal growth factor receptor) (eg, non-small cell lung cancer) gene analysis, common variants (eg, exon 19 LREA deletion, L858R, T790M, G719A, G719S, L861Q)

 

Slide Review

88381-Microdissection, manual

Additional Tests

Test ID Reporting Name Available Separately Always Performed
SLIRV Slide Review in MG No, (Bill Only) Yes

Testing Algorithm

When this test is ordered, slide review will always be performed at an additional charge.

Reporting Name

EGFR Gene, Mutation Analysis, Tumor

Reference Values

An interpretive report will be provided.

Test Classification

This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.
Sanford Laboratories - Fargo Additional Information:

SANFORD INTERFACE BUILD INFORMATION

Result Code Result Code Description
19247 Result Summary
19248 Result
19249 Interpretation
19250 Specimen
19251 Source
19252 Tissue ID
19253 Released By